Orthopedic & Vascular Medicine is categorized under Orthopedic Doctors and Physicians in Philadelphia, PA and active since 2009.
Orthopedic & Vascular Medicine was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 10006 Verree Road, Philadelphia, Pennsylvania PA 19116 or by phoning (215) 969-1820. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orthopedic & Vascular Medicine |
| Address: | 10006 Verree Road, Philadelphia, Pennsylvania 19116 |
| Phone Number: | (215) 969-1820 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 6213910 |
| Share This Business: |
Orthopedic & Vascular Medicine was started in 2009 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Orthopedic & Vascular Medicine by calling the company number (215) 969-1820, as your correspondence is most welcome. Additionally, the physical location of the single location of Orthopedic & Vascular Medicine can be found at the coordinates 40.10523,-75.03293 as well as the street address 10006 Verree Road in Philadelphia, Pennsylvania 19116.
For its online presence, you may visit Orthopedic & Vascular Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.